Jane Street
AUTL

Jane Street’s Autolus Therapeutics AUTL Stock Holding History

Jane Street’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,000
Closed -$76.6K – 9329
2024
Q1 		$76.6K Buy
+12,000
New +$74.9K ﹤0.01% 8631

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street's AUTL Position: Q2 2026 in Review

Jane Street increased its Autolus Therapeutics (AUTL) stake by 22% in Q2 2026, buying an estimated $84.8K and bringing the position to 299,862 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #8123.

Jane Street first reported a position in AUTL in Q2 2020 and has held it in 17 quarters since. The position peaked at $1.43M in Q3 2025. 83 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Jane Street held 299,862 shares of Autolus Therapeutics worth $480K as of Q2 2026.
  • Jane Street bought 54,077 Autolus Therapeutics shares in Q2 2026, an estimated $84.8K.
  • Autolus Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8123 holding.
  • Jane Street first reported a position in Autolus Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Jane Street's Autolus Therapeutics position peaked at $1.43M in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.